Vladimir Coric
Chief Executive Officer chez BIOHAVEN LTD.
Fortune : 172 M $ au 31/03/2024
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
John Childs | M | 81 |
Veradermics, Inc.
Veradermics, Inc. Pharmaceuticals: MajorHealth Technology VeraDermics, Inc. is a clinical-stage biopharmaceutical company that focuses on developing drugs for immunologic and dermatologic diseases. The company is based in San Antonio, TX. The company has a portfolio of five product candidates that target common skin conditions such as warts, hair loss, and eczema. Founded by dermatologists, VeraDermics leverages its clinical experience to identify and advance novel drugs that address specific patient needs and solve pervasive treatment challenges in dermatology practice.
Pyramid Biosciences, Inc.
Pyramid Biosciences, Inc. BiotechnologyHealth Technology Pyramid Biosciences, Inc. operates as a biotechnology company. It develops new therapies focused on the modulation of cell surface. The company was founded by Kollol Pal and Jordan Leef and is headquartered in Waltham, MA. | 10 ans |
Gregory Bailey | M | 68 | 10 ans | |
Julia Gregory | F | 71 | 7 ans | |
Christopher Boerner | M | 53 | 9 ans | |
George Clark | M | - | 5 ans | |
Kimberly Gentile | F | 56 | 23 ans | |
Irina Antonijevic | M | 59 | 2 ans | |
Clifford Bechtold | M | - | 10 ans | |
Kollol Pal | M | - |
Pyramid Biosciences, Inc.
Pyramid Biosciences, Inc. BiotechnologyHealth Technology Pyramid Biosciences, Inc. operates as a biotechnology company. It develops new therapies focused on the modulation of cell surface. The company was founded by Kollol Pal and Jordan Leef and is headquartered in Waltham, MA. | - |
Phil Holzer | M | 48 | 11 ans | |
Michael Heffernan | M | 59 | 4 ans | |
Mark Foley | M | 58 | 7 ans | |
Robert Hugin | M | 69 | 4 ans | |
Douglas Taylor Falk | M | - |
Vita Therapeutics, Inc.
Vita Therapeutics, Inc. BiotechnologyHealth Technology Vita Therapeutics, Inc. is a biotechnology company based in Baltimore, MD that develops state-of-the-art cellular therapeutics for the treatment of neuromuscular diseases and cancers. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita Therapeutics is progressing its co-leading programs VTA-100 and VTA-300 for the treatment of limb-girdle muscular dystrophy (LGMD) and multiple solid tumors with the goal of filing investigational drug applications with the Food and Drug Administration in 2023. The company is developing these proprietary cellular therapies following a dual development strategy beginning with autologous-derived cells before moving to a universal hypoimmunogenic cell line. Vita Therapeutics was founded in 2019 by Douglas Taylor Falk, M.S. and Peter Andersen, Ph.D. Douglas Taylor Falk has been the CEO since 2019. | 5 ans |
Douglas G. Gray | M | - | - | |
Kishan Mehta | M | 38 | 3 ans | |
Matthew Buten | M | 62 | 3 ans | |
James Engelhart | M | 60 |
Our Lady of Mercy Academy
| 6 ans |
Jordan Leef | M | - |
Pyramid Biosciences, Inc.
Pyramid Biosciences, Inc. BiotechnologyHealth Technology Pyramid Biosciences, Inc. operates as a biotechnology company. It develops new therapies focused on the modulation of cell surface. The company was founded by Kollol Pal and Jordan Leef and is headquartered in Waltham, MA. | - |
Jennifer Porcelli | F | - | 2 ans | |
David Saunders | M | - | 4 ans | |
Brian Lestini | M | - |
Pyramid Biosciences, Inc.
Pyramid Biosciences, Inc. BiotechnologyHealth Technology Pyramid Biosciences, Inc. operates as a biotechnology company. It develops new therapies focused on the modulation of cell surface. The company was founded by Kollol Pal and Jordan Leef and is headquartered in Waltham, MA. | 3 ans |
Tobin Schilke | M | 49 | 6 ans | |
Timothy Durso | M | - |
Veradermics, Inc.
Veradermics, Inc. Pharmaceuticals: MajorHealth Technology VeraDermics, Inc. is a clinical-stage biopharmaceutical company that focuses on developing drugs for immunologic and dermatologic diseases. The company is based in San Antonio, TX. The company has a portfolio of five product candidates that target common skin conditions such as warts, hair loss, and eczema. Founded by dermatologists, VeraDermics leverages its clinical experience to identify and advance novel drugs that address specific patient needs and solve pervasive treatment challenges in dermatology practice. | - |
Irfan Qureshi | M | - | - | |
Paloma Moraleda | F | - | 2 ans | |
Melissa Beiner | M | - | 7 ans | |
Christian Nolet | M | 67 | 5 ans | |
Louis Schmukler | M | - | 13 ans | |
Gastón Ortega | M | - | 2 ans | |
Dwight Moxie | M | 48 | 4 ans | |
Jill Beraud | F | 63 | 5 ans | |
Julian Gangolli | M | 66 | 8 ans | |
Olivia Ware | F | 67 | 3 ans | |
Carey Kolaja | F | 51 | 3 ans | |
Megan M. Dow | M | - | 4 ans | |
Angus Russell | M | 68 | 13 ans | |
Patricia Zandy | F | - |
Yale School of Medicine
| - |
Deborah Jagielow | F | - |
Yale School of Medicine
| - |
Pasko Rakic | M | - |
Yale School of Medicine
| - |
Daniel Petrylak | M | - |
Yale School of Medicine
| - |
Marcella Nunez-Smith | F | - |
Yale School of Medicine
| - |
Daniel DiCapua | M | - |
Yale School of Medicine
| - |
David Hollander | M | 50 | 2 ans | |
Lajos Pusztai | M | - |
Yale School of Medicine
| - |
Christopher Loose | M | 43 |
Yale School of Medicine
| 10 ans |
Chris Barrett | M | - | - | |
Howard L. Haronian | M | 63 |
Yale School of Medicine
| 30 ans |
Kathleen Walsh | F | 68 |
Yale School of Medicine
| - |
Mark Nuttall | M | - |
Vita Therapeutics, Inc.
Vita Therapeutics, Inc. BiotechnologyHealth Technology Vita Therapeutics, Inc. is a biotechnology company based in Baltimore, MD that develops state-of-the-art cellular therapeutics for the treatment of neuromuscular diseases and cancers. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita Therapeutics is progressing its co-leading programs VTA-100 and VTA-300 for the treatment of limb-girdle muscular dystrophy (LGMD) and multiple solid tumors with the goal of filing investigational drug applications with the Food and Drug Administration in 2023. The company is developing these proprietary cellular therapies following a dual development strategy beginning with autologous-derived cells before moving to a universal hypoimmunogenic cell line. Vita Therapeutics was founded in 2019 by Douglas Taylor Falk, M.S. and Peter Andersen, Ph.D. Douglas Taylor Falk has been the CEO since 2019. | - |
Eva Chin | F | - |
Vita Therapeutics, Inc.
Vita Therapeutics, Inc. BiotechnologyHealth Technology Vita Therapeutics, Inc. is a biotechnology company based in Baltimore, MD that develops state-of-the-art cellular therapeutics for the treatment of neuromuscular diseases and cancers. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita Therapeutics is progressing its co-leading programs VTA-100 and VTA-300 for the treatment of limb-girdle muscular dystrophy (LGMD) and multiple solid tumors with the goal of filing investigational drug applications with the Food and Drug Administration in 2023. The company is developing these proprietary cellular therapies following a dual development strategy beginning with autologous-derived cells before moving to a universal hypoimmunogenic cell line. Vita Therapeutics was founded in 2019 by Douglas Taylor Falk, M.S. and Peter Andersen, Ph.D. Douglas Taylor Falk has been the CEO since 2019. | - |
Erica Jordan | F | - | - | |
Rita Berkson | F | - |
Yale School of Medicine
| - |
Arjun Kalyanpur | M | 59 |
Yale School of Medicine
| - |
Warren Volles | M | - | - | |
James Rothman | M | 74 |
Yale School of Medicine
| - |
Harvey J. Berger | M | 74 |
Yale School of Medicine
| - |
Karl Insogna | M | - |
Yale School of Medicine
| - |
Peter Cresswell | M | - |
Yale School of Medicine
| - |
Michael William Cleman | M | - |
Yale School of Medicine
| - |
Caroline Dircks | M | - | 4 ans | |
Shuai Li | M | - | 7 ans | |
Michael S. Kaminer | M | 62 |
Yale School of Medicine
| - |
Biren Amin | M | 51 |
Pyramid Biosciences, Inc.
Pyramid Biosciences, Inc. BiotechnologyHealth Technology Pyramid Biosciences, Inc. operates as a biotechnology company. It develops new therapies focused on the modulation of cell surface. The company was founded by Kollol Pal and Jordan Leef and is headquartered in Waltham, MA. | 2 ans |
Raymond Sanchez | M | 63 |
Yale School of Medicine
| - |
Maryellen McQuade | F | - | - | |
Jessica Serra | F | - | - | |
Azita Nejad | F | - | 10 ans | |
Reid Waldman | M | - |
Veradermics, Inc.
Veradermics, Inc. Pharmaceuticals: MajorHealth Technology VeraDermics, Inc. is a clinical-stage biopharmaceutical company that focuses on developing drugs for immunologic and dermatologic diseases. The company is based in San Antonio, TX. The company has a portfolio of five product candidates that target common skin conditions such as warts, hair loss, and eczema. Founded by dermatologists, VeraDermics leverages its clinical experience to identify and advance novel drugs that address specific patient needs and solve pervasive treatment challenges in dermatology practice. | - |
Jon Blaskovich | M | - | - | |
Lisa Stocking | F | - | - | |
Conor Gallagher | M | - | 6 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
James Cornelius | M | 81 | 10 ans | |
Thomas Lynch | M | 63 |
Yale School of Medicine
| 10 ans |
Dustin Sjuts | M | 45 | 6 ans | |
Elyse Stock | M | 66 | 5 ans | |
Robert Berman | M | 61 | 10 ans | |
Declan Doogan | M | 72 | 8 ans | |
John E. Celentano | M | 64 | 31 ans | |
James Robinson | M | 88 | 29 ans | |
Carl Decicco | M | 62 | 10 ans | |
David Loomis | M | - | 5 ans | |
St John McGrath | M | - | 9 ans | |
Louis J. Freeh | M | 74 | 8 ans | |
John Tilton | M | 56 | 6 ans | |
Charles Conway | M | 62 | 5 ans | |
Dinesh C. Paliwal | M | 67 | 8 ans | |
Jason Haddock | M | 54 | 14 ans | |
Robert Repella | M | 65 | 2 ans | |
Michael Grobstein | M | 81 | 13 ans | |
Robert Williams | M | 75 | 7 ans | |
Béatrice J. Cazala | F | 67 | 32 ans | |
Brian Daniels | M | 65 | 14 ans | |
Charles Sigal | M | 72 | 16 ans | |
Eric Aguiar | M | 62 | 4 ans | |
Gerald Storch | M | 67 | 12 ans | |
Leif Valdemar Johansson | M | 73 | 13 ans | |
Alan J. Lacy | M | 70 | 12 ans | |
Togo Dennis West | M | 81 | 10 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 99 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Vladimir Coric
- Réseau Personnel